Loomis Sayles & CO L P Biogen Inc. Transaction History

Loomis Sayles & CO L P

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $2,477 - $2,862	-9 Reduced 45.0%	11 $3,000
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $5,131 - $5,846	20 New	20 $6,000
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $2,712 - $3,417	14 Added 46.67%	44 $9,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $12,451 - $16,238	-44 Reduced 59.46%	30 $8,000
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $8,806 - $14,100	34 Added 85.0%	74 $26,000
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $9,718 - $11,385	40 New	40 $11,000
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $1.02 Million - $1.59 Million	-4,701 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $1.28 Million - $1.62 Million	-4,602 Reduced 49.47%	4,701 $1.42 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $6.2 Million - $8.1 Million	-21,109 Reduced 69.41%	9,303 $3.29 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $4.94 Million - $5.88 Million	-19,168 Reduced 38.66%	30,412 $8.83 Million
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $167,523 - $236,934	-644 Reduced 1.28%	49,580 $13.6 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $2.26 Million - $2.53 Million	-7,350 Reduced 12.77%	50,224 $16 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $1.11 Million - $1.3 Million	-3,934 Reduced 6.4%	57,574 $18 Million
Q2 2017 Aug 14, 2017	BUY	N/A	61,508	61,508 $16.7 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.